These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer. Koelbl H, Schieder K, Neunteufel W, Bieglmayer C. Neoplasma; 1989 Dec; 36(4):473-8. PubMed ID: 2770933 [Abstract] [Full Text] [Related]
6. [Clinical evaluation of the tumor marker CA125 in ovarian tumor (a cooperative study among 8 institutions)]. Kato T, Nishimura H, Hamai J, Yamabe T, Nakajima H, Nakano T, Noda K, Teshima K, Suzuki H, Ueda G. Nihon Gan Chiryo Gakkai Shi; 1985 Dec 20; 20(10):2338-45. PubMed ID: 3007640 [No Abstract] [Full Text] [Related]
7. [Comparative study of 3 markers in ovarian cancer: CA 125, CA 19,9 and CEA]. Vigné E, Krebs B, Khater R, Mira R, Boublil JL, Jourlait A, Frenay M, Namer M. J Gynecol Obstet Biol Reprod (Paris); 1986 Dec 20; 15(5):609-13. PubMed ID: 3463621 [Abstract] [Full Text] [Related]
10. The value of epithelial membrane antigen in the diagnosis of ovarian tumors. Fujimoto I, Hirai Y, Hasumi K, Masubuchi K, Osamura Y. Acta Cytol; 1990 Dec 20; 34(4):549-54. PubMed ID: 1695804 [Abstract] [Full Text] [Related]
12. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms]. Yabushita H, Masuda T, Hattori A, Noguchi M, Ito Y, Nakanishi M, Ishihara M. Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep 20; 37(9):1883-92. PubMed ID: 2997349 [Abstract] [Full Text] [Related]